Zhonghong Pulin Medical Products Co.Ltd(300981)
Independent directors’ opinions on the seventh meeting of the third board of directors
Independent opinions on relevant matters
In accordance with the company law of the people’s Republic of China, the rules for independent directors of listed companies, the Listing Rules of GEM stocks of Shenzhen Stock Exchange (revised in 2022), the self regulatory guidelines for listed companies of Shenzhen Stock Exchange No. 2 – standardized operation of GEM listed companies and other laws, regulations, normative documents and the relevant provisions of the articles of association, As an independent director of Zhonghong Pulin Medical Products Co.Ltd(300981) (hereinafter referred to as “the company”), with a serious and responsible attitude and based on an independent, prudent and objective position, we express our independent opinions on the relevant matters of the seventh meeting of the third board of directors as follows:
1、 Independent opinions on using self owned idle funds to invest in low-risk financial products
On the premise of ensuring normal operation and capital safety, the company uses its own funds to purchase financial products, which is conducive to improving the use efficiency of the company’s funds and increasing investment income, which is in line with the interests of the company and all shareholders. The decision-making procedures for purchasing wealth management products with self owned funds this time comply with the provisions of the Shenzhen Stock Exchange gem stock listing rules (revised in 2022), Shenzhen Stock Exchange listed companies self regulatory guidance No. 2 – standardized operation of GEM listed companies, and the decision-making procedures are legal and compliant.
We agree to the proposal that the company use its own idle funds to invest in low-risk financial products, and agree to submit it to the general meeting of shareholders for deliberation.
2、 Independent opinions on cash management using temporarily idle over raised funds and their interests
The company makes reasonable use of some temporarily idle over raised funds and their interests for cash management, which helps to improve the efficiency and income of the company’s funds. There is no behavior of changing the purpose of the raised funds in a disguised form, which does not affect the construction of the raised funds and the normal operation of the company, which is in line with the interests of the company and its shareholders; The relevant approval procedures comply with the guidelines for the supervision of listed companies No. 2 – regulatory requirements for the management and use of raised funds by listed companies, the rules for the listing of shares on the gem of Shenzhen Stock Exchange (revised in 2022) The self regulatory guidelines for listed companies of Shenzhen Stock Exchange No. 2 – standardized operation of GEM listed companies and the company’s measures for the administration of raised funds and other relevant provisions do not harm the interests of minority shareholders.
We agree to the proposal that the company use the temporarily idle over raised funds and their interests for cash management, and agree to submit it to the general meeting of shareholders for deliberation.
3、 Independent opinions on the application of the company and its subsidiaries for comprehensive credit line from the bank in 2022 and the guarantee provided by the company for the application of comprehensive credit line by its subsidiaries
The credit line applied for this time is within the scope of the daily needs of the company’s production and operation. The guaranteed object of the guarantee is the wholly-owned subsidiary of the company. Its business activities are uniformly managed by the company and the business risk is controllable. The guarantee behavior considered by the board of directors this time belongs to the normal business activities of the company, and the guarantee will not damage the interests of the company.
We agree that the company and its holding subsidiaries apply for credit lines and guarantees from banks and other financial institutions, and agree to submit them to the general meeting of shareholders for deliberation.
4、 Independent opinions on carrying out foreign exchange derivatives trading business in 2022
Since the company’s import and export business requires a large number of foreign exchange transactions, the company and its holding subsidiaries use reasonable financial instruments to lock in transaction costs, which is conducive to avoiding the risk of exchange rate fluctuations. The foreign exchange derivatives transactions carried out by the company and its holding subsidiaries are closely related to the daily business needs, and the company has established corresponding monitoring mechanisms, which comply with the provisions of relevant laws and regulations.
After comprehensively considering the economic development and financial trend outside China, the expectation of exchange rate fluctuation and the business scale of the company, we agree to the proposal on carrying out foreign exchange derivatives trading business in 2022.
Independent directors: Mao Fugen, Guo Xiaodong and Li Kuncheng February 23, 2002
